Leave Your Message
ADT1411-MOR202 Biosimilar-Anti-CD38 mAb-Research Grade
Antibody

ADT1411-MOR202 Biosimilar-Anti-CD38 mAb-Research Grade

  • Catalog Number ADT1411
  • Host CHO Cells
  • Species Human
  • Target CD38
  • Application Elisa, WB

Alpha Lifetech provides pre-sales and after-sales services for our products, and our blocking antibody solutions will provide technical support for your research.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

CD38 is a type II transmembrane glycoprotein with a short N-terminal cytoplasmic tail and a large extracellular C-terminal domain.

Product Specification

Catalog Number

ADT1411

Product Name

ADT1411-MOR202 Biosimilar-Anti-CD38 mAb-Research Grade

Alternate Names

anti-cd38,  cd38 antibody,  anti-cd38 antibody,  anti-cd38 monoclonal antibody,  anti cd38 antibody,  mouse cd38,  human cd38,  anti-mouse cd38 antibody,  recombinant cd38,  cd38 antibodies,  cd38 recombinant antibody,  cd38 blocking antibody

Alias

MOR202

Clonity

Monoclonal

Host

CHO Cells

Species

Human

Target

CD38

Gene ID

952

Isotype

IgG1-nd

Size

1mg, 5mg

Research Area

Immunology

Product Description

Felzartamab is under investigation in clinical trial NCT04145440 (Trial to Assess Safety and Efficacy of MOR202 in Anti-pla2r + Membranous Nephropathy (Amn)).

Mechanism of Action

MOR202 is a monoclonal antibody targeting CD38,  a protein involved in immune regulation and cancer progression.

Metabolism

MOR202 has a long half-life and distributes throughout the bloodstream and tissues.

Application

Elisa,  WB

Purity

>95% as determined by SDS-PAGE

Concentration

batch dependent

Buffer

Supplied in PBS, PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only.

Reactivity

Human

Reference

1. Ghosh A,  et al. Front Immunol,  2023. PMID 37180151
2. Kitada M,  et al. Cells,  2023 Feb 12. PMID 36831262
3. Tao Y,  et al. Mol Cell Proteomics,  2023 Mar. PMID 36804530